Research reportAlterations in GLUT1 and GLUT3 glucose transporter gene expression following unilateral hypoxia–ischemia in the immature rat brain
Introduction
Glucose is the primary cerebral energy substrate for the adult, as well as the immature brain, and it is the only substrate able to sustain metabolism under anaerobic conditions. The delivery of glucose to the brain involves its passage across the endothelial cells of the blood–brain barrier (BBB) and the cell membranes of neurons and glia. These processes are mediated by the facilitative glucose transporter proteins: 55 kDa GLUT1 in the BBB, 45 kDa in choroid plexus and ependyma and in non-vascular brain, predominantly glia, and GLUT3 in neurons 8, 18, 37. The levels of these proteins are quite low in the immature rat brain and can be limiting to cerebral glucose utilization 34, 38. We have previously demonstrated that unilateral cerebral hypoxia–ischemia in the immature rat of sufficient duration to produce severe brain damage, results in significant alterations in both GLUT1 and GLUT3 proteins, in both ipsilateral (damaged) and contralateral (undamaged) hemispheres during the initial 24 h of recovery [39]. Major alterations in cerebral energy metabolism and glucose utilization, as well as several changes in gene expression also characterize this interval of recovery. The biochemical changes include altered levels of brain glucose, and brain-to-blood glucose ratios, increased lactate levels, and falling levels of ATP and phosphocreatine, reflective of the imbalance in the relationship between substrate supply and energy demand occurring during the evolution of the hypoxic–ischemic brain damage 26, 31, 33, 43. All of these studies involved hemispheric determinations of glucose transporter protein or metabolite levels, and thus do not provide any regional definition of selective alterations. More recent studies have demonstrated that additional early changes include induction of several immediate early and stress-response genes, such as c-fos and hsp70, observed throughout the affected hemisphere 1, 4, 22. The purpose of this study was to determine whether GLUT1 or GLUT3 gene expression is part of the early stress response in the immature brain and also to determine the temporal relationship between mRNA and protein expression. In addition, since reliable immunocytochemical localization of the glucose transporter proteins in brain is difficult, in situ hybridization analysis provides a regional definition of hypoxia/ischemia-induced alterations in GLUT1 and GLUT3 expression.
Section snippets
Materials and methods
Dated, pregnant Wistar rats (Charles River, Wilmington, DE) were housed in individual cages and fed standard laboratory chow ad libitum. Offspring were delivered vaginally and litter size adjusted to 10 pups/litter on the day of delivery. Hypoxia–ischemia was induced in 7-day old (P7) rat pups following ligation of the right common carotid artery as previously described 27, 39. Prior to exposure to hypoxia (8% O2/92% N2), pups were placed in open 500-ml glass jars in a water bath maintained at
Results
The normal pattern of GLUT1 gene expression in rodent brain, as measured by in situ hybridization analysis, is characterized by an intense punctate signal in microvessels and in ependyma, with a less intense and more diffuse signal throughout the parenchyma, as illustrated in the control brain of Fig. 1. The effect of hypoxia–ischemia on GLUT1 gene expression is also depicted in Fig. 1, in the two coronal sections taken at the level of the striatum and anterior hippocampus, obtained from a
Discussion
This study demonstrates that the evolution of brain damage from hypoxia–ischemia in the neonatal rat involves major alterations in the expression of GLUT1 and GLUT3 glucose transporter mRNAs. Although previous studies have examined the effects of global or focal ischemia on brain glucose transporter expression in adult rodent models 8, 12, 20, 21, this is the first study to describe the immediate/early and delayed responses of both GLUT1 and GLUT3 gene expression following unilateral cerebral
Acknowledgements
The authors wish to acknowledge the expert technical assistance of Robert Brucklacher, Tina Rutherford and Lisa Seaman. This research was supported by Grant No. R29 HD31521(SJV) and PO1 HD30704(RCV) from the National Institute of Child Health and Human Development.
References (44)
- et al.
Changes in c-fos mRNA in the neonatal rat brain following hypoxic ischemia
Neurosci. Lett.
(1994) - et al.
Ontogeny and cellular distribution of brain glucose transporter gene expression
Mol. Cell. Neurosci.
(1992) - et al.
Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct cis-acting sequences
J. Biol. Chem.
(1995) - et al.
GLUT1 and GLUT3 gene expression in gerbil brain following brief ischemia: an in situ hybridization study
Mol. Brain Res.
(1994) - et al.
Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
J. Biol. Chem.
(1995) - et al.
Expression of two glucose transporters, GLUT1 and GLUT3, in cultured cerebellar neurons: evidence for neuron-specific expression of GLUT3
Mol. Cel. Neurosci.
(1991) - et al.
Modulation of expression of glucose transporters, GLUT3 and GLUT1, by potassium and N-methyl-d-aspartate in cultured cerebellar granule neurons
Mol. Cell. Neurosci.
(1994) - et al.
Progressive hippocampal loss of immunoreactive GLUT3, the neuron-specific glucose transporter, after global forebrain ischemia in the rat
Brain Res.
(1995) - et al.
Localization of c-fos, c-jun, and hsp70 mRNA expression in brain after neonatal hypoxia–ischemia
Dev. Brain Res.
(1994) - et al.
Glucose transporter expression in brain
J. Biol. Chem.
(1992)
Influence of age on the cerebral lesions in an immature rat model of cerebral hypoxia–ischemia: a light microscopic study
Dev. Br. Res.
Glucose deprivation causes posttranscriptional enhancement of brain capillary endothelial glucose transporter gene expression via GLUT1 mRNA stabilization
J. Neurochem.
Regional expression of c-fos and heat shock protein-70 mRNA following hypoxia–ischemia in the immature rat brain
J. Cereb. Blood Flow Metab.
Kinetics of blood–brain barrier transport of pyruvate, lactate, and glucose in suckling, weaning and adult rats
J. Neurochem.
Cis-element/cytoplasmic protein interaction within the 3′-untranslated region of the GLUT1 glucose transporter mRNA
J. Neurochem.
Hypoxia increases glucose transport at blood–brain barrier
J. Appl. Physiol.
Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures
FASEB J.
The early reactions of non-neuronal cells to brain injury
Annu. Rev. Neurosci.
Ischemic injury induces brain glucose transporter gene expression
Endocrinology
Coordinate IGF-1 and IGFBP5 gene expression in perinatal rat brain after hypoxia–ischemia
J. Cereb. Blood Flow Metab.
Hypoxia induces glucose transporter expression in endothelial cells
Am. J. Physiol.
Glucose transporter proteins in brain
FASEB J.
Cited by (108)
Intracellular energy production and distribution in hypoxia
2023, Journal of Biological ChemistryNanomedicine for brain cancer
2022, Advanced Drug Delivery ReviewsCitation Excerpt :Moreover, the accumulation of the glucose-installed multi-PEGylated antibodies selectively occurred in the tumors, but was negligible in healthy brain [222,434]. Such selective GLUT1-mediated transport into tumors may be related to the enhanced levels and subcellular distribution of the transporter on the ECs of tumors due to changes in metabolic homeostasis, including hypoxia and nutrient deprivation, and extracellular signals promoting tumor proliferation [224-231]. Moreover, the position of GLUT1 on the cells can be altered according to metabolic requirements, changing from vesicular compartments inside the cells to the apical/basal surface of cells, and vice versa [228-231].
Glucose transporter 3 in neuronal glucose metabolism: Health and diseases
2021, Metabolism: Clinical and ExperimentalHyperbaric oxygen toxicity in brain: A case of hyperoxia induced hypoglycemic brain syndrome
2019, Medical Hypotheses
- 1
Present address: Merck Clinical Pharmacology, Rahway, NJ 07065, USA.
- 2
Present address: Department of Pathology, University of Melbourne, Parkville, VIC 3952, Australia.